BiopharmaTrend.com

Verge Genomics

Verge Genomics

Private company
VERGE GENOMICS

We are pioneering a better drug discovery process using systems biology to improve the lives of people with neurodegenerative disorders. YC S15.

Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.


Founded
2015
Status
Private company
Geography
United States of America based
Funding
$36.120 M
Research papers
33

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page